跳至主要内容
临床试验/JPRN-jRCTs071220048
JPRN-jRCTs071220048已完成1 期

Angiogenesis augmentation therapy for indirect revascularization of moyamoya disease using G-CSF - EDFAPS-G

Morioka Motohiro0 个研究点目标入组 5 人开始时间: 2022年8月29日最近更新:

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 60age old(—)
性别
All

入选标准

  • 1.Moyamoya disease requiring direct/indirect revascularization.
  • 2.Age:20-60 years old.
  • 3.Obtain informed consent by the document.

排除标准

  • 1.Splenomegaly or splenic lesions on abdominal echo.
  • 2.Leukocytosis more than 15000/mm3
  • 3.Past histries of symptomatic intracranial hemorrhage, bleeding tendency or coagulating disorders.
  • 4.Hyper reactivity to G-CSF.
  • 5.Congestive heart failure or uncontrollable angina.
  • 6.Thrombocytopenia(less than 140000/mm3)
  • 7.Liver dysfunction(AST(GOT),ALT(GPT) more than 100 IU/L)
  • 8.Renal dysfunction (creatinine 1.5mg/dl and more)
  • 9.Difficult to continue this trial due to social problems, etc.
  • 10.Join other clinical trials.
  • 11.Inappropriate to enroll in this trial by the judgment of the doctor.

研究者

发起方
Morioka Motohiro

相似试验